CSIMarket
 


Bioscience Neutraceuticals Inc   (JBCT)
Other Ticker:  
 
    Sector  Retail    Industry Specialty Retail
   Industry Specialty Retail
   Sector  Retail
 

JBCT's Capital Expenditures Growth by Quarter and Year

Bioscience Neutraceuticals Inc 's Capital Expenditures results by quarter and year




JBCT Capital Expenditures (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 0.00 0.00 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.00



JBCT Capital Expenditures fourth quarter 2019 Y/Y Growth Comment
Bioscience Neutraceuticals Inc in the fourth quarter 2019 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the fourth quarter 2019, Bioscience Neutraceuticals Inc achieved the best Capital Expenditures growth in Specialty Retail industry. While Bioscience Neutraceuticals Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the fourth quarter 2019.




JBCT Capital Expenditures ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Bioscience Neutraceuticals Inc 's fourth quarter 2019 Capital Expenditures $ 0.00 millions JBCT's Income Statement
Bioscience Neutraceuticals Inc 's fourth quarter 2018 Capital Expenditures $ 0.00 millions Quarterly JBCT's Income Statement
New: More JBCT's historic Capital Expenditures Growth >>


JBCT Capital Expenditures (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Capital Expenditures fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Specialty Retail Industry #
Retail Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Specialty Retail Industry #
Retail Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Bioscience Neutraceuticals Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


JBCT's IV. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Specialty Retail Industry #
Retail Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Specialty Retail Industry #
Retail Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


JBCT's IV. Quarter Q/Q Capital Expenditures Comment


Bioscience Neutraceuticals Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Dec 31 2019 period, Bioscience Neutraceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Bioscience Neutraceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Specialty Retail Industry #
Retail Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Dec 31 2019 period, Bioscience Neutraceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Bioscience Neutraceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Specialty Retail Industry #
Retail Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Specialty Retail Industry Capital Expenditures Growth Trends and Statistics
Retail Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
JBCT's Capital Expenditures Growth Ratio versus Specialty Retail Industry, Retail Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for JBCT's Competitors
Capital Expenditures Growth for Bioscience Neutraceuticals Inc 's Suppliers
Capital Expenditures Growth for JBCT's Customers

You may also want to know
JBCT's Annual Growth Rates JBCT's Profitability Ratios JBCT's Asset Turnover Ratio JBCT's Dividend Growth
JBCT's Roe JBCT's Valuation Ratios JBCT's Financial Strength Ratios JBCT's Dividend Payout Ratio
JBCT's Roa JBCT's Inventory Turnover Ratio JBCT's Growth Rates JBCT's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Dec 31 2019 within Retail SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2019
Mckesson Corporation-1.91%$ -1.911 millions
Cvs Health Corporation-3.08%$ -3.077 millions
Amerinac Holding Corp -3.51%$ -3.505 millions
O Reilly Automotive Inc-4.52%$ -4.523 millions
Ezcorp Inc -5.20%$ -5.204 millions
Herbalife Ltd -6.01%$ -6.007 millions
Hanesbrands Inc -7.39%$ -7.392 millions
1 800 Flowers Com Inc-7.65%$ -7.646 millions
Tractor Supply Co-13.83%$ -13.825 millions
Rave Restaurant Group Inc -16.67%$ -16.667 millions
W w Grainger Inc -17.27%$ -17.266 millions
Autonation Inc -20.04%$ -20.039 millions
Party City Holdco Inc -20.85%$ -20.853 millions
Fastenal Co-21.59%$ -21.591 millions
Star Group L p -24.87%$ -24.870 millions
Performance Food Group Company-25.36%$ -25.356 millions
Lithia Motors Inc -26.03%$ -26.032 millions
Qurate Retail Inc -26.21%$ -26.214 millions
Amazon com Inc -27.50%$ -27.505 millions
Baozun Inc -27.67%$ -27.666 millions
Domino s Pizza Inc -28.63%$ -28.629 millions
Western Capital Resources Inc -30.40%$ -30.401 millions
Aerogrow International Inc -32.39%$ -32.386 millions
Climb Global Solutions inc -39.13%$ -39.130 millions
Carvana Co -44.90%$ -44.902 millions
Travelcenters Of America Inc -45.30%$ -45.304 millions
School Specialty Inc-48.41%$ -48.405 millions
Beyond inc -51.70%$ -51.703 millions
Penske Automotive Group Inc -51.75%$ -51.751 millions
Nu Skin Enterprises Inc -52.69%$ -52.692 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com